| Pharicin B stabilizes retinoic acid receptor-alpha and presents synergistic differentiation induction with ATRA in myeloid leukemic cells | |
Gu, Zhi-Min1,2; Wu, Ying-Li1; Zhou, Mei-Yi1; Liu, Chuan-Xu1; Xu, Han-Zhang1; Yan, Hua3; Zhao, Yong4; Huang, Ying1; Sun, Han-Dong4 ; Chen, Guo-Qiang1,2
| |
| 2010-12-09 | |
| 发表期刊 | BLOOD
 |
| 卷号 | 116期号:24页码:5289-5297 |
| 摘要 | All-trans retinoic acid (ATRA), a natural ligand for the retinoic acid receptors (RARs), induces clinical remission in most acute promyelocytic leukemia (APL) patients through the induction of differentiation and/or eradication of leukemia-initiating cells. Here, we identify a novel natural ent-kaurene diterpenoid derived from Isodon pharicus leaves, called pharicin B, that can rapidly stabilize RAR-alpha protein in various acute myeloid leukemic (AML) cell lines and primary leukemic cells from AML patients, even in the presence of ATRA, which is known to induce the loss of RAR-alpha protein. Pharicin B also enhances ATRA-dependent the transcriptional activity of RAR-alpha protein in the promyelocytic leukemia-RAR alpha-positive APL cell line NB4 cells. We also showed that pharicin B presents a synergistic or additive differentiation-enhancing effect when used in combination with ATRA in several AML cell lines and, especially, some primary leukemic cells from APL patients. In addition, pharicin B can overcome retinoid resistance in 2 of 3 NB4-derived ATRA-resistant subclones. These findings provide a good example for chemical biology-based investigations of pathophysiological and therapeutic significances of RAR-alpha and PML-RAR-alpha proteins. The effectiveness of the ATRA/pharicin B combination warrants further investigation on their use as a therapeutic strategy for AML patients. (Blood. 2010;116(24):5289-5297) |
| DOI | 10.1182/blood-2010-02-267963 |
| 收录类别 | SCI |
| 语种 | 英语 |
| WOS记录号 | WOS:000285141200028 |
| 引用统计 | |
| 文献类型 | 期刊论文 |
| 条目标识符 | http://ir.kib.ac.cn/handle/151853/23926 |
| 专题 | 植物化学与西部植物资源持续利用国家重点实验室 |
| 作者单位 | 1.Shanghai Jiao Tong Univ, Dept Pathophysiol, Shanghai Univ E Inst,Chem Biol Div,Sch Med, Key Lab Cell Differentiat & Apoptosis Chinese Min, Shanghai 200025, Peoples R China 2.Chinese Acad Sci, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China 3.SJTU SM, Rui Jin Hosp, Dept Hematol, Shanghai, Peoples R China 4.CAS, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources W, Yunnan, Peoples R China |
| 推荐引用方式 GB/T 7714 | Gu, Zhi-Min,Wu, Ying-Li,Zhou, Mei-Yi,et al. Pharicin B stabilizes retinoic acid receptor-alpha and presents synergistic differentiation induction with ATRA in myeloid leukemic cells[J]. BLOOD,2010,116(24):5289-5297. |
| APA | Gu, Zhi-Min.,Wu, Ying-Li.,Zhou, Mei-Yi.,Liu, Chuan-Xu.,Xu, Han-Zhang.,...&Chen, Guo-Qiang.(2010).Pharicin B stabilizes retinoic acid receptor-alpha and presents synergistic differentiation induction with ATRA in myeloid leukemic cells.BLOOD,116(24),5289-5297. |
| MLA | Gu, Zhi-Min,et al."Pharicin B stabilizes retinoic acid receptor-alpha and presents synergistic differentiation induction with ATRA in myeloid leukemic cells".BLOOD 116.24(2010):5289-5297. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
| 10.1182@blood-2010-0（963KB） | 期刊论文 | 作者接受稿 | 开放获取 | CC BY-NC-SA | 浏览 请求全文 | |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论